Integrated Diagnostics Holdings plc
IDGXF
$0.4591
-$0.009-1.92%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.09% | 2.97% | -5.95% | -13.17% | -9.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.09% | 2.97% | -5.95% | -13.17% | -9.92% |
| Cost of Revenue | 16.78% | -5.89% | -10.11% | -10.85% | -13.47% |
| Gross Profit | 41.66% | 18.32% | 1.38% | -16.57% | -3.27% |
| SG&A Expenses | -0.27% | 0.22% | -16.62% | -11.83% | -2.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -202.51% | -375.90% | -46.81% | -535.42% | -113.26% |
| Total Operating Expenses | 11.73% | -5.79% | -12.22% | -13.05% | -13.21% |
| Operating Income | 100.46% | 40.77% | 21.02% | -13.54% | 12.18% |
| Income Before Tax | 133.85% | -38.21% | 53.20% | -12.80% | 21.07% |
| Income Tax Expenses | 52.36% | 14.87% | -3.36% | -27.47% | 22.33% |
| Earnings from Continuing Operations | 243.95% | -51.60% | 103.74% | -4.63% | 19.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -127.29% | -142.45% | -79.34% | 328.92% | 179.57% |
| Net Income | 130.53% | -55.08% | 56.63% | -2.04% | 44.74% |
| EBIT | 100.46% | 40.77% | 21.02% | -13.54% | 12.18% |
| EBITDA | 71.23% | 25.67% | 8.41% | -15.56% | 3.51% |
| EPS Basic | 135.00% | -53.47% | 59.32% | 0.00% | 48.15% |
| Normalized Basic EPS | 72.73% | -41.25% | 17.81% | -1.12% | 44.74% |
| EPS Diluted | 135.00% | -53.47% | 59.32% | 0.00% | 48.15% |
| Normalized Diluted EPS | 72.73% | -41.25% | 17.81% | -1.12% | 44.74% |
| Average Basic Shares Outstanding | -3.11% | -3.11% | -2.13% | -2.13% | 0.00% |
| Average Diluted Shares Outstanding | -3.11% | -3.11% | -2.13% | -2.13% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |